Skip to main content

Advertisement

SpringerLink
Log in

Incadronate disodium inhibits joint destruction and periarticular bone loss only in the early phase of rat adjuvant-induced arthritis

  • ORIGINAL ARTICLE
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Destruction of articular cartilage and subchon-dral bone loss in the affected joints of rat adjuvant arthritis have never been quantified histologically. This study aimed to evaluate the effect of incadronate disodium on joint destruction and periarticular bone loss, using histomorphometric measurements. Seven-week-old female Lewis rats were injected with 0.1 mg of heat-killed Mycobacterium butyricum into the tail base. Immediately after sensitization, vehicle, or incadronate at 10 or 100 µg/kg per day, was administered subcutaneously, three times per week. Hind-paw volume was measured weekly and the animals were killed at 2, 4, 6, and 10 weeks after sensitization. After taking X-rays, decalcified sagittal sections of the ankle joint were prepared and stained with toluidine blue and tartarate-resistant acid phosphatase. Articular cartilage destruction and subchondral bone loss were evaluated histomorphometrically. At 2 weeks after sensitization, no radiographic or histologic changes were observed. However, at 4 weeks, severe articular cartilage destruction and subchondral bone loss were found in the arthritic control group, while these changes were inhibited dose-dependently by incadronate treatment. At 6 and 10 weeks, both the destructive changes and the bone loss had further progressed, and they were not inhibited by incadronate treatment. Incadronate dose-dependently inhibited articular cartilage destruction and subchondral bone loss at 4 weeks after sensitization in this adjuvant arthritis model. However, the suppressive effects of incadronate did not continue until 6 and 10 weeks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J Dequeker K Maenaut J Verwilghen R Westhovens (1995) ArticleTitleOsteoporosis in rheumatoid arthritis Clin Exp Rheumatol 13 IssueIDs12 S21–26 Occurrence Handle8846540

    PubMed  Google Scholar 

  2. H Kroger I Arnala V Rehnberg M Hamalainen E Alhava (1994) ArticleTitleHistomorphometry of periarticular bone in rheumatoid arthritis Ann Chir Gynaecol 83 56–62 Occurrence Handle1:STN:280:ByuA3s%2FmslA%3D Occurrence Handle8053640

    CAS  PubMed  Google Scholar 

  3. S Kotake K Sato KJ Kim N Takahashi N Udagawa I Nakamura A Yamaguchi T Kishimoto T Suda S Kashiwazaki (1996) ArticleTitleInterleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast like cell formation. J Bone Miner Res 11 88–95 Occurrence Handle1:CAS:528:DyaK28Xht1Gnurw%3D

    CAS  Google Scholar 

  4. SR Goldring (2002) ArticleTitleBone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol Suppl 65 44–48 Occurrence Handle1:CAS:528:DC%2BD38Xnslehtrk%3D Occurrence Handle12236623

    CAS  PubMed  Google Scholar 

  5. VJ Hajiroussou M Webley (1984) ArticleTitleProlonged low dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis 43 24–27 Occurrence Handle1:STN:280:BiuC38jgtVY%3D

    CAS  Google Scholar 

  6. A D’Angelo A Fabris L Sartori L Malvasi P Travaglia PF Gambari S Todesco (1985) ArticleTitleMineral metabolism and bone mineral content in rheumatoid arthritis. Effect of corticosteroids Clin Exp Rheumatol 3 143–146 Occurrence Handle1:STN:280:BiqB2Mrnt1c%3D Occurrence Handle4017312

    CAS  PubMed  Google Scholar 

  7. L Mosekilde C Hasling PC Tagehoj Jensen F Tagehoj Jensen (1987) ArticleTitleBisphosphonate whole body retention test: relations to bone mineralization rate renal function and bone mineral content in osteoporosis and metabolic bone disorders. Eur J Clin Invest 17 530–537 Occurrence Handle1:CAS:528:DyaL1cXht1Oksb8%3D

    CAS  Google Scholar 

  8. R Valkema FJ Vismans SE Papapoulos EK Pauwels OL Bijvoet (1989) ArticleTitleMaintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD Bone Miner 5 183–192 Occurrence Handle10.1016/0169-6009(89)90095-0 Occurrence Handle1:STN:280:BiaC2M%2FmtFY%3D Occurrence Handle2920240

    Article  CAS  PubMed  Google Scholar 

  9. D Thiebaud P Jaeger C Gobelet AF Jacquet P Burckhardt (1988) ArticleTitleA single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget s disease of bone. Am J Med 85 207–212 Occurrence Handle1:STN:280:BieB1M3jslE%3D

    CAS  Google Scholar 

  10. F Eggelmaeijer SE Papapoulous HC van Paasen (1996) ArticleTitleIncreased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a 3-year randomized, double blind trial. Arthritis Rheum 39 396–402

    Google Scholar 

  11. F Eggelmeijer SE Papapoulos HC van Paassen BA Dijkmans FC Breedveld (1994) ArticleTitleClinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. J Rheumatol 21 2016–2020 Occurrence Handle1:STN:280:ByqC2szovFU%3D

    CAS  Google Scholar 

  12. FP Cantatore CA Acquista V Pipitone (1999) ArticleTitleEvaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate J Rheumatol 26 2318–2323 Occurrence Handle1:CAS:528:DyaK1MXnvVGntrg%3D Occurrence Handle10555884

    CAS  PubMed  Google Scholar 

  13. SH Ralston L Hacking L Willocks F Bruce DA Pitkeathly (1989) ArticleTitleClinical, biochemical, and radiographic effects of aminohydroxypropy lidene bisphosphonate treatment in rheumatoid arthritis. Ann Rheum Dis 48 396–399 Occurrence Handle1:STN:280:BiaB2s3is1U%3D

    CAS  Google Scholar 

  14. A Maccagno E Di Giorgio EJ Roldan LE Caballero A Perez Lloret (1994) ArticleTitleDouble blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis Scand J Rheumatol 23 211–214 Occurrence Handle1:STN:280:ByuA2sjptVI%3D Occurrence Handle8091148

    CAS  PubMed  Google Scholar 

  15. H Valleala L Laasonen MK Koivula J Mandelin C Friman J Risteli YT Konttinen (2003) ArticleTitleTwo-year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. J Rheumatol 30 468–473 Occurrence Handle1:CAS:528:DC%2BD3sXisVKgsrw%3D

    CAS  Google Scholar 

  16. MW Pysklywec EL Moran ER Bogoch (1997) ArticleTitleZoledronate (CGP 42′446), a bisphosphonate protects against metaphyseal intracortical defects in experimental inflammatory arthritis. J Orthop Res 15 858–861 Occurrence Handle1:CAS:528:DyaK1cXhslCrsrs%3D

    CAS  Google Scholar 

  17. P Oelzner R Brauer S Henzgen K Thoss B Wunsche G Hersmann K Abendroth RW Kinne (1999) ArticleTitlePeriarticular bone alterations in chronic antigen-induced arthritis: free and liposome encapsulated clodronate prevent loss of bone mass in the secondary spongiosa. Clin Immunol 90 79–88 Occurrence Handle1:CAS:528:DyaK1MXht1ynsrY%3D

    CAS  Google Scholar 

  18. T Osterman K Kippo L Lauren I Pasanen R Hannuniemi R Sellman (1997) ArticleTitleA comparison of clodronate and indomethacin in the treatment of adjuvant arthritis Inflamm Res 46 79–85 Occurrence Handle1:STN:280:ByiB2MzislI%3D Occurrence Handle9098719

    CAS  PubMed  Google Scholar 

  19. T Osterman K Kippo L Lauren R Hannuniemi R Sellman (1995) ArticleTitleEffect of clodronate on established collagen induced arthritis in rats. Inflamm Res 44 258–263 Occurrence Handle1:CAS:528:DyaK2MXntlKrsrg%3D

    CAS  Google Scholar 

  20. T Osterman K Kippo L Lauren R Hannuniemi R Sellman (1994) ArticleTitleEffect of clodronate on established adjuvant arthritis Rheumatol Int 14 139–147 Occurrence Handle10.1007/BF00579699 Occurrence Handle1:CAS:528:DyaK28XmvVeltg%3D%3D Occurrence Handle7871332

    Article  CAS  PubMed  Google Scholar 

  21. MD Francis K Hovancik RW Boyce (1989) ArticleTitleNE-58095 a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. Int J Tissue React 11 239–252 Occurrence Handle1:CAS:528:DyaK3cXhvFWqsr4%3D

    CAS  Google Scholar 

  22. RW Kinne CB Schmidt-Weber R Hoppe E Buchner E Palombo-Kinne E Nurnberg F Emmrich (1995) ArticleTitleLong-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate containing liposomes. Arthritis Rheum 38 1777–1790 Occurrence Handle1:CAS:528:DyaK28XptlSlug%3D%3D

    CAS  Google Scholar 

  23. RW Kinne CB Schmidt E Buchner R Hoppe E Nurnberg F Emmrich (1995) ArticleTitleTreatment of rat arthritides with clodronate containing liposomes. Scand J Rheumatol Suppl 101 91–97 Occurrence Handle1:STN:280:ByqB28rpsFQ%3D

    CAS  Google Scholar 

  24. H Zhao T Shuto G Hirata Y Iwamoto (2000) ArticleTitleAminobisphosphonate (YM175 inhibits bone destruction in rat adjuvant arthritis. J Orthop Sci 5 397–403 Occurrence Handle1:STN:280:DC%2BD3M%2FitVegtg%3D%3D

    CAS  Google Scholar 

  25. I Yamane H Hagino T Okano M Enokida D Yamasaki R Teshima (2003) ArticleTitleEffect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen induced arthritis. Arthritis Rheum 48 1732–1741 Occurrence Handle10.1002/art.10987 Occurrence Handle1:CAS:528:DC%2BD3sXltlSgu7Y%3D

    Article  CAS  Google Scholar 

  26. NA Sims JR Green M Glatt S Schlict TJ Martin MT Gillespie E Romas (2004) ArticleTitleTargeting osteoclasts with zoledronic acid prevents bone destruction in collagen induced arthritis. Arthritis Rheum 50 2338–2346 Occurrence Handle10.1002/art.20382 Occurrence Handle1:CAS:528:DC%2BD2cXmsVantrg%3D

    Article  CAS  Google Scholar 

  27. P Herrak B Görtz S Hayer K Redlich E Reiter J Gasser H Bergmeister G Kollias JS Smolen G Schett (2004) ArticleTitleZoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis Arthritis Rheum 50 2327–2337 Occurrence Handle10.1002/art.20384 Occurrence Handle1:CAS:528:DC%2BD2cXmsVantrs%3D Occurrence Handle15248234

    Article  CAS  PubMed  Google Scholar 

  28. J Li S Mori Y Kaji T Mashiba J Kawanishi H Norimatsu (1999) ArticleTitleEffect of bisphosphonate (incadronate on fracture healing of long bones in rats. J Bone Miner Res 14 969–979 Occurrence Handle1:CAS:528:DyaK1MXjvFKqur0%3D

    CAS  Google Scholar 

  29. G Arturson OP Jakobsson (1985) ArticleTitleOedema measurements in a standard burn model Burns Incl Therm Inj 12 1–7 Occurrence Handle1:STN:280:BimD2M3nslQ%3D Occurrence Handle4063865

    CAS  PubMed  Google Scholar 

  30. RP Carlson LJ Datko L O’Neill-Davis EM Blazek F DeLustro R Beideman AJ Lewis (1985) ArticleTitleComparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred Wistar rats Int J Immunopharmacol 7 811–826 Occurrence Handle10.1016/0192-0561(85)90043-8 Occurrence Handle1:CAS:528:DyaL28XkvFKqsw%3D%3D Occurrence Handle4077344

    Article  CAS  PubMed  Google Scholar 

  31. K Hayashida T Ochi M Fujimoto H Owaki Y Shimaoka K Ono K Matsumoto (1992) ArticleTitleBone marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis Arthritis Rheum 35 241–245 Occurrence Handle1:CAS:528:DyaK38XhvFagur0%3D Occurrence Handle1734913

    CAS  PubMed  Google Scholar 

  32. M Fujimoto K Hayashida T Ochi H Owaki Y Shimaoka M Okamura et al. (1992) ArticleTitleFluctuation of interleukin-1 and -6 activity in bone marrow serum in collagen-induced arthritis in rats Biomed Res 13 243–251 Occurrence Handle1:CAS:528:DyaK38XmtFSisb4%3D

    CAS  Google Scholar 

  33. T Tamura N Udagawa N Takahashi C Miyaura S Tanaka Y Yamada Y Koishihara Y Ohsugi K Kumaki T Taga et al. (1993) ArticleTitleSoluble interleukin-6 receptor triggers osteoclast formation by interleukin-6 Proc Natl Acad Sci U S A 90 11924–11928 Occurrence Handle1:CAS:528:DyaK2cXnsFWksA%3D%3D Occurrence Handle8265649

    CAS  PubMed  Google Scholar 

  34. Y Suzuki M Tanihara Y Ichikawa A Osanai M Nakagawa M Ide Y Mizushima (1995) ArticleTitlePeriarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells Ann Rheum Dis 54 484–490 Occurrence Handle1:CAS:528:DyaK2MXmslOqtbk%3D Occurrence Handle7632091

    CAS  PubMed  Google Scholar 

  35. M Nakamura T Ando M Abe K Kumagai Y Endo (1996) ArticleTitleContrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice Br J Pharmacol 119 205–212 Occurrence Handle1:CAS:528:DyaK28XmtFSju7g%3D Occurrence Handle8886399

    CAS  PubMed  Google Scholar 

  36. HM Markusse GJ Lafeber FC Breedveld (1990) ArticleTitleBisphosphonates in collagen arthritis Rheumatol Int 9 281–283 Occurrence Handle10.1007/BF00541325 Occurrence Handle1:CAS:528:DyaK3cXhvFWmu74%3D Occurrence Handle2315608

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kagawa, 761-0793, Japan

    Tomoyuki Akiyama, Satoshi Mori, Tasuku Mashiba, Kensaku Miyamoto, Satoshi Komatsubara, Yongping Cao, Takeshi Manabe & Hiromichi Norimatsu

  2. First Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

    Hiroaki Dobashi & Michiaki Tokuda

Authors
  1. Tomoyuki Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tasuku Mashiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kensaku Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satoshi Komatsubara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yongping Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takeshi Manabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiromichi Norimatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroaki Dobashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michiaki Tokuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Mori.

About this article

Cite this article

Akiyama, T., Mori, S., Mashiba, T. et al. Incadronate disodium inhibits joint destruction and periarticular bone loss only in the early phase of rat adjuvant-induced arthritis. J Bone Miner Metab 23, 295–301 (2005). https://doi.org/10.1007/s00774-004-0602-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-004-0602-3

Key words

Search

Navigation